Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT03603730
Status
Recruiting
Apply to this trial

Conditions

  • Dyspepsia
  • Gastroparesis

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • taVNS — DEVICE
    Active or inactive taVNS delivered to the external ear at a moderate, non-painful level.

Study Details

Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.

Key Dates

Start date
Nov 30, 2018
Status verified
May 2025
Primary completion
Jun 30, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
65 participants (estimated)
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: taVNS
    Active or inactive taVNS

Primary Outcome Measure

Neuroimaging [ Time Frame: 2 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Andrew Bolender, BA
[email protected]
617-643-4297
Braden Kuo, MD (SUB_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies